Top

Published in:

01-03-2015 | Hepatobiliary Tumors

Yttrium-90 Radioembolization is a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases: Further Evidence in Support of a New Treatment Paradigm

Authors: Ryan Hickey, MD, Robert Lewandowski, MD, Riad Salem, MD, MBA

Published in: Annals of Surgical Oncology | Issue 3/2015

Excerpt

Saxena et al. provide further evidence of the safety and efficacy of yttrium 90 radioembolization for the treatment of chemorefractory colorectal liver metastases with the publication of outcomes in more than 300 patients treated during a 7-year period. The reported survival rates and low grade of toxicities complement a growing body of evidence in favor of transarterial radioembolization for the treatment of a disease with an otherwise dismal prognosis. Saxena et al. joins a series of recent publications that are helping to define a new and promising treatment paradigm for colorectal liver metastases, which remains one of the most common causes of cancer-related mortality. …

Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(10):1626–1634.PubMedCrossRef

Lewandowski RJ, Memon K, Mulcahy MF, et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Molec Imaging. 2014;41(10):1861–1869.

Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65(2):412–425.PubMedCrossRef

Hickey R, Mulcahy MF, Lewandowski RJ, et al. Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization. Int J Radiat Oncol Biol Phys. 2014;88(5):1025–1031.PubMedCrossRef

Cohen SJ, Konski AA, Putnam S, et al. Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. Br J Cancer. 2014;111(2):265–271.PubMedCrossRef

Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31(5):1237–1248.PubMedCrossRef

Title: Yttrium-90 Radioembolization is a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases: Further Evidence in Support of a New Treatment Paradigm
Authors: Ryan Hickey, MD
Robert Lewandowski, MD
Riad Salem, MD, MBA
Publication date: 01-03-2015
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 3/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-014-4165-9

At a glance: The STEP trials

Springer Medicine

Yttrium-90 Radioembolization is a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases: Further Evidence in Support of a New Treatment Paradigm

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2015

The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer

Delay in Diagnosis and Treatment of Symptomatic Breast Cancer in China

Global Cancer Consortiums: Moving from Consensus to Practice

The Usefulness of Gadoxetic Acid-Enhanced Dynamic Magnetic Resonance Imaging in Hepatocellular Carcinoma: Toward Improved Staging

Gasless Laparoscopically Assisted Transhiatal Esophagectomy for Upper Esophageal Carcinoma

Secondary Malignant Neoplasms after Osteosarcoma: Early Onset and Cumulative Alkylating Agent Dose Dependency